Objective: Interleukin (IL)-18 has been reported to be an important predictor for mortality in ischemic heart disease. IL-18 has proinflammatory properties, induces cell death and stimulates nitric oxide production. We hypothesized that following myocardial infarction (MI) an increased myocardial IL-18 production occurs, which may be involved in the pathogenesis of post-ischemic heart failure. Methods and Results: Seven days after induction of MI in the mouse, myocardial hypertrophy and pulmonary edema were observed. RNase protection assay of tissue from the non-infarcted left ventricular myocardium revealed an increase in IL-18 (2.0-fold; P,0.001) and IL-1b (1.6-fold; P,0.001) mRNA after MI. Enhanced abundance of pro-IL-18 (1.4-fold; P,0.05), IL-18 receptor (3.5-fold; P,0.05) and IL-18 binding proteins (1.6-fold; P,0.05) was also demonstrated, whereas cardiac IL-18 protein decreased by 25% (P,0.05) following MI. However, the concentration of circulating IL-18 was significantly elevated (MI; 90.4611.7 pg / ml, sham; 47.264.2 pg / ml; P,0.001). After MI, enhanced cardiac activity of the pro-IL-18 processing enzyme, caspase-1, was measured. Additionally, a 3.4-fold increase (P,0.001) in the activity of the IL-18 degrading enzyme, caspase-3, was found in cardiac tissue, which may explain the observed reduction of cardiac IL-18 protein abundance. Finally, IL-18 reduced shortening of electrically stimulated adult cardiomyocytes and left ventricular contractility in vivo. Conclusions: After MI in the mouse, increased production of cardiac IL-18 mRNA and pro-IL-18, as well as circulating IL-18 occurs. Since IL-18 also reduced myocardial contractility, we suggest that IL-18 may be involved in the pathogenesis of contractile dysfunction following MI.
I ncreased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction a,b , a,b a a
. Introduction
18, termed IL-18 binding protein (IL-18BP), acts as a natural antagonist and is considered to be a regulator of Interleukin (IL)-18 is a member of the IL-1 cytokine IL-18 bioactivity [5] . family and has structural similarities with IL-1b [1] . In IL-18 is a proinflammatory cytokine [6] . It stimulates unstimulated cells, IL-18 is present primarily in the production of inducible nitric oxide synthase (iNOS) [7] , inactive precursor form pro-IL-18 [2] . The intrinsic protumor necrosis factor (TNF)-a [8] , and the combination of cessing of pro-IL-18 by caspase-1, also known as IL-1b-IL-18 and IL-12 synergistically induces interferon (IFN)-g converting enzyme (ICE), leads to secretion of mature [9] , which previously has been shown to depress myocar-IL-18 [3] , whereas caspase-3 degrades mature IL-18 to dial contractility [10] . Moreover, IL-18 enhances the inactive metabolites [4] . A soluble decoy receptor of ILactivity of cytotoxic T-lymphocytes (CTL) [6, 11] and induces synthesis of intercellular adhesion molecule (ICAM)-1 [12] . Both CTL and ICAM-1 have been re-2 .2. Cytokine and caspase mRNA measurements ported to be associated with development of cardiac dysfunction [13, 14] .
The gene expression of IL-12p35, IL-12p40, IL-10, Recently, Pomerantz et al. [15] have shown in an IL-1b, IL-1 receptor antagonist (Ra), macrophage migraischemia / reperfusion model that inhibition of caspase-1 tion inhibitory factor (MIF), IL-18, IFN-g, IL-6 and of reduces contractile dysfunction in isolated human atrial caspase-8, -3, -6, -11, -2, -7, -1 and -14 in the nontrabeculae. Furthermore, IL-18 has been reported to be an infarcted region of the LV myocardium was analyzed using important predictor for mortality in ischemic heart disease commercially available kits (RiboQuant, Pharmingen, San [16] . However, cardiac production and processing of IL-18 Diego, CA) and antisense RNA multiprobes (mCK2b and as well as its role in development of cardiac dysfunction mAPO-1, Pharmingen) according to the manufacturer's following myocardial infarction (MI) still remain undeprotocol. fined. The biological actions of IL-18, as well as its
The densities of the RNase protection assay bands were structural and functional relationship with IL-1b, makes it determined with a phosphor imaging system (Fujifilm conceivable that IL-18 contributes to development of the Bio-imaging Analyser BAS-1800, Fuji Photo Film Co., post-ischemic heart failure syndrome. Therefore, the Tokyo, Japan) and quantified using the software Image characterization of the IL-18 processing during heart Gauge 3.12 (Fuji Photo Film Co., Ltd., Tokyo, Japan). failure may allow development of new therapeutic strateThe L32 bands were quantified separately after 3 h, gies. In this context, we hypothesized that following MI a whereas the cytokine bands were determined 16 h later. local cardiac de novo synthesis and elevated levels of
The mRNA expression data presented were normalized to circulating IL-18 occur, and that IL-18 reduces myocardial the mean value of the two L32 bands. (8, 12 or 15%), transferred to polyvinyl difluoride Eighty-seven male BALB-C mice, 5-6 weeks old, were membranes, blocked overnight in 10% non-fat dry milk at anesthetized and operated as previously described [17] .
4 8C and incubated with primary antibodies. The following Briefly, a left thoracotomy was performed and a silk suture antibodies were used: mature IL-18: anti-human IL-18 (8-0) was placed in the interventricular groove directly (RDI-IL18abRx, Research Diagnostics Inc; 15% SDS-gel), underneath the left atrium. Myocardial blanching was pro-IL-18: anti-mouse IL-18 (sc-6179, Santa Cruz Bioobserved to ensure that the left coronary artery was technology, Inc; 15% SDS-gel), IL-18Ra: anti-mouse ILoccluded. Sham operated mice (sham) underwent the same 18Ra (AF-856, R&D Systems; 8% SDS-gel), IL-18BP: surgical procedure except that no ligature was placed.
anti-mouse IL-18BPc and IL-18BPd (sc-9464, Santa Cruz After 7 days the mice were sacrificed with excision of Biotechnology, Inc; 12% SDS-gel) and caspase-1 p20: heart, lungs, liver and spleen. Heart and lungs were anti-mouse caspase-1 p20 (sc-1218, Santa Cruz Biotechweighed immediately, and rapidly snap frozen in liquid nology, Inc; 12% SDS-gel). Antibody binding was denitrogen. Before freezing, left ventricles from MI-mice tected by the ECL-system (Amersham Life Sciences). were divided into infarcted area and remaining non-infarRecombinant mouse IL-18 (B 002-5) and mouse IL-18BPd cted area, which were easily distinguished macroscopical-(122-BP, both R&D Systems) were used as positive ly. Care was taken to avoid that the border-zone was controls. included in the non-infarcted area. From sham hearts only left ventricular (LV) myocardium was used. Blood samples were collected following puncture of the right ventricle. (Japan), according to the manufacturer's protocol. The detection limit for IL-18 using this kit is 25.0 pg / ml.
.4. Enzyme-linked immunosorbent assay

.5. Caspase-1 and caspase-3 activity
Homogenates of non-infarcted and infarcted LV myocardium were prepared as previously described by Fauvel et al. [19] . Activities of caspase-1 and caspase-3 were determined using CaspACEீ Assay System (Promega) . After three washes in Immunohistochemical analysis was performed on hearts TBS the primary antibody was labeled for 30 min using from sham (n52) and MI-mice (n52). Kidney tissue the DAKO EnVisionீ1, Peroxidase, Rabbit K4010 sys-(n52) served as positive control. The excised hearts were tem and 3,39-diaminobenzidine tetrahydrochloride as the placed in ice-cold phosphate-buffered saline (pH 7.4), chromogen. Sections were counterstained with hematoembedded in Tissue-Tekீ O.C.T. compound (Sakura xylin for 1-2 min, mounted and examined in a Leitz Finetek, Torrance, CA, USA) and rapidly frozen in dry Aristoplan microscope. ice-cooled isopropanol and stored at 270 8C until further processed. Then 5-mm thick sections were cut, collected on  Superfrost Plus slides (Menzel-Glaser, Braunschweig, 2 .7. Measurements of cardiomyocyte function Germany) and fixed for 5 min in acetone at 220 8C and air-dried. After rinsing in Tris-buffered saline (TBS, pH Adult ventricular myocytes were isolated from hearts of 7.6) containing 0.05% Tween 20, sections were incubated male Wistar rats as previously described by Holt et al. with the DAKO Peroxidase Blocking Reagent (DAKO, [20] . Myocytes on laminated coverslips were placed in an Glostrup, Denmark) for 15 min at 37 8C followed by TBS open perfused cell bath and superfused with HEPES The relative levels of pro-IL-18 and mature IL-18 carotid artery and advanced into the left ventricle. For proteins in hearts from sham, and in the non-infarcted and intravenous infusion, a 0.6 mm silicon tube connected to a infarcted regions of the LV myocardium from MI-mice are micro-infusion pump (Model CMA / 100, CMA / Mishown in Fig. 2A-D . Following MI, there was a 1.4-and crodialysis, Solna, Sweden) was positioned in the right 2.1-fold increase in pro-IL-18 protein content in the noninternal jugular vein. A volume of 0.2 ml 0.9% NaCl infarcted ( Fig. 2A) and infarcted (Fig. 2B ) LV myocar-(n54) or 0.2 ml NaCl containing 500 ng mouse IL-18 (B dium, respectively. The mature IL-18 protein content 002-5, R&D Systems; n54) was infused during a time decreased by 25% in the non-infarcted (Fig. 2C ) and by period of 5 min. LV1dP/dt was recorded before, and 5 79% in the infarcted (Fig. 2D ) LV myocardium. Reduced and 15 min after infusion. Data from 10 consecutive beats mature IL-18 protein content was also found in the nonwere recorded in DASYLab version 5.1 software (Datalog, infarcted region of the LV 3 days after induced MI (datä National Instruments Company, Monchengladbach, Gernot shown). We detected relatively high levels of mature many) and analyzed using a program designed in a IL-18 in cardiac tissue, whereas the 18 kDa band repre- commercially available software package (MATLAB , senting mature IL-18 was absent in lung, liver and spleen The MathWorks, Inc., Natick, MA, USA).
tissue both in sham and MI-mice (Fig. 2E) Fig. 2G . The serum concentration of IL-18 GmbH, Erkrath, Germany). A P,0.05 was considered was significantly elevated in MI-mice (90.4611.7 pg / ml) statistically significant. compared to sham (47.264.2 pg / ml).
.5. Immunohistochemical localization of IL-18 . Results
Specific IL-18 staining was detected in smooth muscle 3 .1. Characterization of the animals cells and endothelial cells both in cardiac (Fig. 2H) and kidney (Fig. 2I) tissues. No specific staining was seen in Mean body weights, heart weights and lung weights in cardiomyocytes or macrophages. No obvious differences sham and MI-mice are shown in Table 1 . Before surgery were observed between tissues from MI-mice and sham. there was no significant difference in body weight between sham and MI-mice. When sacrificed, 7 days after the 3 .6. Cardiac IL-18Ra protein primary operation, we observed significant lower body weight in MI-mice. MI-mice showed significantly inThe relative levels of the a-chain of the IL-18R protein in hearts from sham and in non-infarcted and infarcted LV 3 .8. Cardiac production of caspases and caspase activity myocardium from MI-mice are shown in Fig. 3 . Following MI, there was a 3.5-fold increase in the IL-18Ra protein Caspase-8, -3, -6, -11, -2, -7, -1 and -14 mRNA content in the non-infarcted region (Fig. 3A) and a 2.8-fold expression and the relative protein abundance of caspase-1 increase in the infarcted region (Fig. 3B) IL-18BP (glycosylated) |65 kDa (Fig. 3D) , respectively. shown).
Sham, ** P,0.001 vs. Sham.
subunit p20 in sham hearts and in non-infarcted LV the amount of the active protein caspase-1 p20 was found myocardium from MI-mice are shown in Table 2 , and in in MI-mice. Additionally, MI-mice showed a 4.0-and a Fig. 4A and B. There was no significant increase in the 2.2-fold increase in caspase-1 like activity (Fig. 4C ) in the cardiac gene expression of the IL-18 processing enzyme, non-infarcted and infarcted region of the LV myocardium, caspase-1, following MI. However, a 2.1-fold increase in respectively. Moreover, a 3.3-, 1.5-and a 2.1-fold increase 
. Discussion
In the present study, we report for the first time increased IL-18 gene expression and elevated levels of pro-IL-18 in cardiac tissue 1 week after induction of MI in the mouse. Moreover, the levels of circulating IL-18, cardiac IL-18Ra and IL-18BP were found to be increased, and IL-18 reduced shortening in isolated cardiomyocytes and decreased left ventricular contractility in vivo. The content of mature IL-18 in cardiac tissue was reduced after MI together with a substantial increase in the activity of the pro-IL-18 and IL-18 processing enzymes caspase-1 and -3.
The increase in IL-18 gene expression was associated with enhanced expression of IL-1b, but we did not observe increased expression of IL-12. IL-18 was originally discovered as a factor that induces IFN-g production from Th1 lymphocytes in the presence of IL-12 [9] . One week following MI, our study revealed no detectable IFN-g mRNA in the non-infarcted left ventricular myocardium. In a similar model of MI in rats, Varda-Bloom et al. [21] showed no significant increase in lymphocyte proliferation as early as 1 week after MI. Thus, a lack of significant lymphocyte proliferation in the non-infarcted myocardium at this time point may explain why we found no detectable gene expression of IFN-g in our study. Therefore, our 
